Substance P, opioid, and catecholamine systems in the mouse central nervous system (CNS).
Hill
R G
RG
Pharmacology Department, Neuroscience Research Centre, Merck, Sharp, and Dohme, Harlow, Essex CM20 2QR, United Kingdom. hillr@merck.com
D000818:Animals; D002395:Catecholamines / Q000502:physiology*; D002490:Central Nervous System / Q000502:physiology*; D004299:Dopamine beta-Hydroxylase / Q000172:deficiency / Q000235:genetics; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009619:Nociceptors / Q000502:physiology; D018847:Opioid Peptides / Q000502:physiology*; D010146:Pain / Q000503:physiopathology; D018040:Receptors, Neurokinin-1 / Q000502:physiology; D013373:Substance P / Q000502:physiology*
D002395:Catecholamines; D018847:Opioid Peptides; D018040:Receptors, Neurokinin-1; D013373:Substance P; D004299:Dopamine beta-Hydroxylase